Pacer Advisors, Inc. Ionis Pharmaceuticals Inc Transaction History

Pacer Advisors, Inc.

$39 Billion
Q2 2024

A detailed history of Pacer Advisors, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 960 shares of IONS stock, worth $38,457. This represents 0.0% of its overall portfolio holdings.

Number of Shares

960

Previous 971 1.13%

Holding current value

$38,457

Previous $42,000 7.14%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$36.45 - $47.7 $400 - $524	-11 Reduced 1.13%	960 $45,000
Q1 2024 May 10, 2024	BUY	$42.03 - $53.55 $40,811 - $51,997	971 New	971 $42,000
Q2 2021 Jul 21, 2021	SELL	$34.54 - $47.25 $50,808 - $69,504	-1,471 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$42.51 - $63.78 $59,939 - $89,929	-1,410 Reduced 48.94%	1,471 $66,000
Q4 2020 Jan 20, 2021	BUY	$45.3 - $60.27 $48,924 - $65,091	1,080 Added 59.97%	2,881 $163,000
Q3 2020 Oct 19, 2020	BUY	$47.45 - $62.95 $85,457 - $113,372	1,801 New	1,801 $85,000
Q3 2019 Oct 10, 2019	SELL	$59.06 - $72.15 $1.2 Million - $1.47 Million	-20,333 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$62.09 - $86.14 $1.26 Million - $1.75 Million	20,333 New	20,333 $1.31 Million
Q1 2019 Apr 10, 2019	SELL	$52.92 - $81.17 $640,649 - $982,644	-12,106 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$43.37 - $59.54 $268,330 - $368,373	6,187 Added 104.53%	12,106 $654,000
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $253,806 - $317,850	5,919 New	5,919 $305,000
Q1 2018 May 14, 2018	SELL	$44.08 - $55.05 $87,366 - $109,109	-1,982 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $703,143 - $900,107	-13,979 Reduced 87.58%	1,982 $100,000
Q3 2017 Nov 08, 2017	BUY	$45.56 - $59.57 $727,183 - $950,796	15,961	15,961 $809,000

Others Institutions Holding IONS

# of Institutions

394

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.69B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Ionis Pharmaceuticals Inc Transaction History